Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain

Fig. 2

Quality of Life: T-scores (with 95% CIs) for Quality of Life PROMIS-43 subdomains (Fatigue, Sleep, and Social Function); and ACPA Quality of Life scale, by dosing subgroups between Baseline, Week 2, and Week 4 measurements. Dose −: (N = 16) dose decreased at Week 2 study visit; Dose + : (N = 28) dose increased at Week 2 study visit

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us